Shares of Co-Diagnostics, Inc. (CODX) are up more than 5% in the morning trade on Monday at $6.29.
The molecular diagnostics company today said it has shipped testing reagents for monkeypox virus to one of its international distributors.
As of July 7, 2022, over 6,000 cases of monkeypox have been reported to WHO from 59 countries, the company said.
CODX has traded in the range of $3.66-$11.82 in the past 52 weeks.
Source: Read Full Article
Lates News:
-
Eos Energy Soars On $500 Mln Plan To Increase Production
-
Markets Welcome Debt Deal, Await Jobs Data To Confirm Fed Pause
-
Church & Dwight Slips 7% On Tepid Outlook
-
Deere & Company Drops On Tepid Outlook
-
Bitcoin Predicted To Soar Past $35,000 By Summer As Wallets Holding At Least 1 BTC Hits The 1 Million Mark
